EC
MRK icon

Elequin Capital’s Merck MRK Stock Holding History

Elequin Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.25K Sell
27
-15
-36% -$1.73K ﹤0.01% 436
2025
Q4 		$4.42K Buy
+42
New +$3.94K ﹤0.01% 313
2025
Q2 		– Sell
-44
Closed -$3.95K – 477
2025
Q1 		$3.95K Sell
44
-41
-48% -$3.83K ﹤0.01% 304
2024
Q4 		$8.46K Buy
+85
New +$8.76K ﹤0.01% 365
2023
Q4 		– Sell
-2,200
Closed -$226K – 446
2023
Q3 		$226K Buy
2,200
+2,064
+1,518% +$222K 0.04% 101
2023
Q2 		$15.7K Buy
+136
New +$15.4K 0.01% 254
2022
Q4 		– Sell
-77
Closed -$7K – 682
2022
Q3 		$7K Sell
77
-255
-77% -$22.8K ﹤0.01% 297
2022
Q2 		$30K Buy
+332
New +$29.4K 0.01% 170

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Elequin Capital's MRK Position: Q1 2026 in Review

Elequin Capital reduced its Merck (MRK) stake by 36% in Q1 2026, selling an estimated $1.73K and leaving 27 shares worth $3.25K. The position accounts for ﹤0.01% of the portfolio, ranked #436.

Elequin Capital first reported a position in MRK in Q2 2022 and has held it in 8 quarters since. The position peaked at $226K in Q3 2023. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Elequin Capital held 27 shares of Merck worth $3.25K as of Q1 2026.
  • Elequin Capital sold 15 Merck shares in Q1 2026, an estimated $1.73K.
  • Merck made up ﹤0.01% of Elequin Capital's portfolio in Q1 2026, its #436 holding.
  • Elequin Capital first reported a position in Merck in Q2 2022 and has held it in 8 quarters since.
  • Elequin Capital's Merck position peaked at $226K in Q3 2023.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Elequin Capital's 13F filing for Q1 2026, filed 11 May 2026.